TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

SAMSON MEDCL

Infectious DiseaseDermatology
Generics

SAMSON MEDCL is a generic drug manufacturer focused on Infectious Disease, Dermatology. Key products include VANCOMYCIN HYDROCHLORIDE.

2006
Since
6
Drugs
-
Trials
13
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

CEFAZOLIN SODIUM 2026-02-13
Efficacy
CEFAZOLIN SODIUM 2025-12-01
Manufacturing (CMC)
VANCOMYCIN HYDROCHLORIDE 2025-10-02
CEFAZOLIN SODIUM 2025-08-21
Labeling
CEFAZOLIN SODIUM 2025-08-21
Labeling
CEFAZOLIN SODIUM 2025-08-21
Labeling
VANCOMYCIN HYDROCHLORIDE 2025-05-29
Labeling
VANCOMYCIN HYDROCHLORIDE 2025-03-21
CEFAZOLIN SODIUM 2024-12-18
Efficacy
VANCOMYCIN HYDROCHLORIDE 2024-07-30
Manufacturing (CMC)
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 67%
4 drugs
Dermatology 33%
2 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology
COSETTE other
Dermatology, Infectious Disease
BAUSCH AND LOMB specialty
Infectious Disease, Dermatology